gpt-dict.com

乾酪乳桿菌代田株 (養樂多菌) Lactobacillus casei Shirota (LcS) × 便秘

結論：證據支持但有警示

本案具備明確 strain-exact 證據：L2 列出 5 篇 strain-match=exact 之 RCT/SR（含 2010 系統性回顧明確點名 LcS、2025 RCT 證實 OR 0.

C 🟠 C 有限證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示

本案具備明確 strain-exact 證據：L2 列出 5 篇 strain-match=exact 之 RCT/SR（含 2010 系統性回顧明確點名 LcS、2025 RCT 證實 OR 0.34 顯著減少硬便、2021 憂鬱症患者便秘 RCT、2011 健康族群 RCT、2003 慢性便秘臨床試驗），且 TFDA 以「胃腸功能改善」核發多張小綠人健字號（A00032/A00121/A00122/A00123/A00128/A00178），屬全球最具規模之 strain-specific 益生菌人體試驗組合之一。

然而扣分因素：(1) ACG/AGA 2023 成人便秘指引完全未提及益生菌、ESPGHAN/NASPGHAN 2014 明確不建議兒童使用益生菌治療便秘；(2) 主要 RCT 樣本量偏中小型且亞洲族群為主；(3) EFSA 2010 駁回 LcS 健康宣稱（雖標的為上呼吸道而非便秘，仍顯示歐盟監管對 LcS 全面性質疑）。

綜合考量 strain-exact 證據強度高但權威臨床指引保留，等級訂為 B 而非 A。

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.52
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 附警語發布
信心度
68%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）

各層「支持此療效」的程度

分數越低＝該層越不支持
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.62
L11 AI 複核獨立判讀
0.65
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.517
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative)，由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials
PMID: 25099542 2014 統合分析 n = 1,182
結論：Pooled probiotics improved transit time (-12.4 h), stool frequency (+1.3 BM/wk, 95% CI 0.7-1.9) and consistency (SMD +0.55), but the strain-specific analysis found Lactobacillus casei Shirota did NOT significantly improve stool frequency (WMD -0.2 BM/wk, 95% CI -0.8 to 0.9) or consistency (SMD +0.26, 95% CI -0.30 to 0.82); benefit was driven by Bifidobacterium lactis.
🟢 高品質 混合資助 效應量：LcS-specific: stool frequency WMD -0.2 BM/wk (95% CI -0.8 to 0.9, NS); consistency SMD +0.26 (95% CI -0.30 to 0.82, NS)
前往 PubMed
Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation
PMID: 14631461 2003 RCT (double-blind) n = 70
結論：LcS produced significant improvement in self-reported constipation severity and stool consistency from week 2 (P<0.0001), with a positive effect in 89% of LcS vs 56% of placebo subjects at study end (P=0.003).
效應量：Responders 89% LcS vs 56% placebo (P=0.003)
前往 PubMed
Effect of Daily Consumption of a Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota (LcS) on Stool Consistency in United States Adults with Hard or Lumpy Stools: A Randomized Controlled Trial
PMID: 40024315 2025 RCT (open-label) n = 50
結論：LcS reduced the odds of having hard/lumpy stools in >=25% of BMs (OR 0.34, 95% CI 0.14-0.80, P=0.014) and improved constipation-specific quality of life (PAC-QOL, P=0.003), but the trial was open-label and a surrogate stool-consistency endpoint rather than a constipation diagnosis.
⚠️ 廠商資助 效應量：OR 0.34 for HLS in >=25% of BMs (95% CI 0.14-0.80, P=0.014)
前往 PubMed
Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population
PMID: 21322768 2011 RCT (open-label) n = 39
結論：The proportion of subjects with frequent hard/lumpy stools fell from 73.7% to 36.8% on LcS while rising from 75.0% to 85.0% in controls (P=0.002), with significantly improved Bristol stool score (P<0.001), but in a healthy (non-clinically-constipated) population and non-blinded.
🟠 品質有限 ⚠️ 廠商資助 效應量：Hard/lumpy-stool subjects 73.7%->36.8% (LcS) vs 75.0%->85.0% (control), P=0.002
前往 PubMed
Effects of Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
PMID: 34209804 2021 RCT (double-blind) n = 82
結論：There was NO significant difference in total PAC-SYM constipation-symptom scores between LcS and placebo overall; only some sub-items (rectal/stool symptoms, items 7-12) and the inflammatory marker IL-6 (P<0.05) differed, so the primary constipation endpoint was null.
效應量：Total PAC-SYM: no significant LcS vs placebo difference (null on primary endpoint)
前往 PubMed
Systematic review of randomised controlled trials: probiotics for functional constipation
PMID: 20039451 2010 系統性回顧 n = 377
結論：This earlier qualitative systematic review reported a favourable effect of B. lactis DN-173 010, L. casei Shirota and E. coli Nissle 1917 on defecation frequency and stool consistency, but rated the evidence preliminary and was later superseded by the strain-specific meta-analysis (PMID 25099542) that found LcS itself non-significant.
🟠 品質有限 效應量：Qualitative 'favourable' for LcS; no pooled effect size reported
前往 PubMed

L4a US FDA
支持
GRN No. 429 — Lactobacillus casei strain Shirota. Intended Use: As an ingredient in fermented dairy products at a maximum level of 4x10^8 colony forming units per milliliter. FDA Response: has no questions. Notifier: Yakult Honsha Co., Ltd. (Tokyo, Japan). Filed April 10, 2012; closed December 10, 2012. 來源↗
L4b EU EFSA
反對
The Panel concluded that a cause and effect relationship has not been established between the consumption of Lactobacillus casei Shirota and maintenance of the upper respiratory tract defence against pathogens by maintaining immune defences. The Panel considered that there was no human study demonstrating an effect of Lactobacillus casei Shirota consumption on upper respiratory tract infections… 來源↗
L4c UK NHS
謹慎
Probiotics are generally classed as food rather than medicine, which means they don't go through the rigorous testing medicines do. ... There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). ... If you have an existing health condition or a weakened immune system, you should talk to a doctor before taking any … 來源↗
L4d TW TFDA / 衛福部
支持
養樂多活菌發酵乳 衛署健食字第A00032號 胃腸功能改善；養樂多300LIGHT活菌發酵乳 衛署健食字第A00128號 免疫調節、輔助調整過敏體質、胃腸功能改善；養樂多300活菌發酵乳 衛署健食字第A00178號 胃腸功能改善 來源↗
L4e WHO
中性
Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. The 2002 FAO/WHO Working Group Guidelines for the Evaluation of Probiotics in Food require strain-level identification (genus, species, strain), in vitro testing (acid/bile tolerance), safety assessment (antibiotic resistance, metabolic activities, no transferable resistance), and… 來源↗

L5a NIH Office of Dietary Supplements
中性
With a total listing of over 500 scientific studies...it is fair to say that the L. casei strain Shirota is the most researched probiotic strain in the world. Classified as Lacticaseibacillus paracasei Shirota since April 2020. 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
中性
— 本適應症無對應資料
L5d Harvard Health
支持
Probiotics increased 'gut transit time' by 12.4 hours, increased weekly bowel movements by 1.3, and softened stools. 來源↗
L5e Specialty Society (condition-mapped)
中性
The AGA-ACG Clinical Practice Guideline on the Pharmacological Management of Chronic Idiopathic Constipation (2023) makes strong recommendations for polyethylene glycol, sodium picosulfate, linaclotide, plecanatide, and prucalopride, and discusses fiber, osmotic/stimulant laxatives, secretagogues, and serotonin agonists; probiotics (including Lactobacillus casei Shirota / LcS / Yakult) are not … 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽

PTT BeautyBody 板原 PO 以「低熱量藍瓶養樂多一天兩瓶、約兩週半」分享便秘明顯改善的個人經驗，後續推文亦有「一天一瓶、兩三天即天天順暢」的回饋；不過多數討論並未明確指名 LcS（代田菌）這個菌株，而是把養樂多與一般「益生菌」混為一談，需提醒讀者社群多為品牌經驗而非嚴格的菌株特異性討論。

💬社群實感

多數正面

破解迷思 社群最常見的 5 個誤解
✓
事實把養樂多等同於一般益生菌，忽略代田菌（LcS）為其專屬菌株
✓
事實認為喝越多越有效，事實上官方說明一天 1 瓶即達建議攝取量
✓
事實誤以為養樂多零脂肪就無熱量負擔，忽略糖分高
✓
事實把養樂多當作小兒便秘的長期解方，但兒科社群多反對因含糖量過高
✓
事實認為「乳酸菌都會被胃酸殺死」，但代田菌株具耐酸耐膽汁特性
🩹 社群通報的副作用
  • 一次喝多瓶導致腹瀉
  • 長期飲用後效果遞減（習慣化）
  • 高糖分造成體重或血糖負擔
  • 蛀牙風險（兒童使用者尤其常被提及）
🏷️ 社群熱議品牌

依論壇被提及頻率，非銷售或品質排序。

  • 養樂多（紅瓶經典款）
  • 新養樂多（含半乳寡糖）
  • 養樂多低糖藍瓶
  • Yakult 1000（日本版／全聯獨賣）
  • 可爾必思（常被拿來比較）
  • 亞當樂（被提及的平價類似品）

⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

養樂多活菌發酵乳 衛署健食字第A00032號 (2003/01/21) 申請商：養樂多股份有限公司；有效成分：代田乳酸菌 (Lactobacillus casei Shirota)；保健功效：胃腸功能改善 — 幫助增加腸內益生菌、幫助減少腸內害菌（產氣莢膜桿菌）、幫助改善腸內細菌菌相。養樂多300LIGHT 為唯一獲得國家三項健康食品認證之產品：胃腸功能改善、免疫調節、輔助調整過敏體質。

代表來源 ↗
L10b · TFDA 法定身份 官方認定
✅健康食品（小綠人）

養樂多300（金蓋）獲衛生署健康食品認證字號 衛署健食字第A00178號，每瓶含 Lactobacillus casei Shirota 300 億個以上，具有助於增加腸內益生菌、減少有害菌之保健功效。

來源 ↗

  • 增加膳食纖維攝取
  • 滲透性瀉劑（如聚乙二醇 PEG）
  • 刺激性瀉劑（如番瀉葉）
✓ PMID 可查證引用皆附 NCBI PubMed 原始連結
🔬 6 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-09 claim_version: v8 engine_version: v1.0 claim_id: CLM-COND-constipation-INT-lactobacillus-casei-shirota-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-constipation-INT-lactobacillus-casei-shirota-001/",
  "datePublished": "2026-06-09",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "乾酪乳桿菌代田株 (養樂多菌)能改善便秘",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 有限證據"
  }
}